1. Saeedi, P, Petersohn, I, Salpea, P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract 2019; 157: 107843.
Google Scholar | Crossref2. Einarson, TR, Acs, A, Ludwig, C, et al. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol 2018; 17: 83.
Google Scholar | Crossref | Medline3. Abate, N, Chandalia, M. Ethnicity and type 2 diabetes: focus on Asian Indians. J Diabetes Complications 2001; 15: 320–327.
Google Scholar | Crossref | Medline4. Millett, ERC, Peters, SAE, Woodward, M. Sex differences in risk factors for myocardial infarction: cohort study of UK Biobank participants. BMJ 2018; 363: k4247.
Google Scholar | Crossref | Medline5. Malmborg, M, Schmiegelow, MDS, Nørgaard, CH, et al. Does type 2 diabetes confer higher relative rates of cardiovascular events in women compared with men? Eur Heart J 2020; 41: 1346.
Google Scholar | Crossref | Medline6. Kautzky-Willer, A, Harreiter, J, Pacini, G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev 2016; 37: 278–316.
Google Scholar | Crossref | Medline7. Emerging Risk Factors Collaboration et al., Sarwar, N, Gao, P. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375: 2215–2222.
Google Scholar | Crossref | Medline8. Peters, SAE, Huxley, RR, Woodward, M. Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia 2014; 57: 1542–1551.
Google Scholar | Crossref | Medline9. Peters, SAE, Huxley, RR, Woodward, M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775 385 individuals and 12 539 strokes. Lancet 2014; 383: 1973–1980.
Google Scholar | Crossref | Medline10. Shah, AD, Langenberg, C, Rapsomaniki, E, et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people. Lancet Diabetes Endocrinol 2015; 3: 105–113.
Google Scholar | Crossref | Medline11. Ohkuma, T, Komorita, Y, Peters, SAE, et al. Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals. Diabetologia 2019; 62: 1550–1560.
Google Scholar | Crossref | Medline12. Wright, AK, Kontopantelis, E, Emsley, R, et al. Cardiovascular risk and risk factor management in type 2 diabetes mellitus. Circulation 2019; 139: 2742–2753.
Google Scholar | Crossref | Medline13. Chase-Vilchez, AZ, Chan, IHY, Peters, SAE, et al. Diabetes as a risk factor for incident peripheral arterial disease in women compared to men: a systematic review and meta-analysis. Cardiovasc Diabetol 2020; 19: 151.
Google Scholar | Crossref | Medline14. Bots, SH, Peters, SAE, Woodward, M. Sex differences in coronary heart disease and stroke mortality: a global assessment of the effect of ageing between 1980 and 2010. BMJ Glob Health 2017; 2: e000298.
Google Scholar | Crossref | Medline15. Laverty, AA, Bottle, A, Kim, SH, et al. Gender differences in hospital admissions for major cardiovascular events and procedures in people with and without diabetes in England: a nationwide study 2004–2014. Cardiovasc Diabetol 2017; 16: 100.
Google Scholar | Crossref | Medline16. Anand, SS, Islam, S, Rosengren, A, et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J 2008; 29: 932–940.
Google Scholar | Crossref | Medline17. Ballotari, P, Venturelli, F, Greci, M, et al. Sex differences in the effect of type 2 diabetes on major cardiovascular diseases: results from a population-based study in Italy. Int J Endocrinol 2017; 2017: 1–9.
Google Scholar | Crossref18. Norhammar, A, Stenestrand, U, Lindback, J, et al. Women younger than 65 years with diabetes mellitus are a high-risk group after myocardial infarction: a report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA). Heart 2008; 94: 1565–1570.
Google Scholar | Crossref | Medline19. Canto, JG, Rogers, WJ, Goldberg, RJ, et al. Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA 2012; 307: 813–822.
Google Scholar | Crossref | Medline20. Raffort, J, Lareyre, F, Clément, M, et al. Diabetes and aortic aneurysm: current state of the art. Cardiovasc Res 2018; 114: 1702–1713.
Google Scholar | Crossref | Medline21. Kannel, WB, McGee, DL. Update on some epidemiologic features of intermittent claudication: the Framingham Study. J Am Geriatr Soc 1985; 33: 13–18.
Google Scholar | Crossref | Medline22. Jelani, QU, Petrov, M, Martinez, SC, et al. Peripheral arterial disease in women: an overview of risk factor profile, clinical features, and outcomes. Curr Atheroscler Rep 2018; 20: 40.
Google Scholar | Crossref | Medline23. Schramm, K, Rochon, P. Gender differences in peripheral vascular disease. Semin Interv Radiol 2018; 35: 9–16.
Google Scholar | Crossref | Medline24. Gardner, AW, Parker, DE, Montgomery, PS, et al. Diabetic women are poor responders to exercise rehabilitation in the treatment of claudication. J Vasc Surg 2014; 59: 1036–1043.
Google Scholar | Crossref | Medline25. Magnant, JG, Cronenwett, JL, Walsh, DB, et al. Surgical treatment of infrainguinal arterial occlusive disease in women. J Vasc Surg 1993; 17: 67–78. discussion 76-68.
Google Scholar | Crossref | Medline26. Kannel, WB, Hjortland, M, Castelli, WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974; 34: 29–34.
Google Scholar | Crossref | Medline27. From, AM, Scott, CG, Chen, HH. The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study. J Am Coll Cardiol 2010; 55: 300–305.
Google Scholar | Crossref | Medline28. Parks, RJ, Howlett, SE. Sex differences in mechanisms of cardiac excitation – contraction coupling. Pflugers Arch 2013; 465: 747–763.
Google Scholar | Crossref | Medline29. Murphy, E, Amanakis, G, Fillmore, N, et al. Sex differences in metabolic cardiomyopathy. Cardiovasc Res 2017; 113: 370–377.
Google Scholar | Crossref | Medline30. De Smedt, D, De Bacquer, D, De Sutter, J, et al. The gender gap in risk factor control: effects of age and education on the control of cardiovascular risk factors in male and female coronary patients. The EUROASPIRE IV study by the European Society of Cardiology. Int J Cardiol 2016; 209: 284–290.
Google Scholar | Crossref | Medline31. Juutilainen, A, Kortelainen, S, Lehto, S, et al. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care 2004; 27: 2898–2904.
Google Scholar | Crossref | Medline32. Wannamethee, SG, Papacosta, O, Lawlor, DA, et al. Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women’s Heart Health Study. Diabetologia 2012; 55: 80–87.
Google Scholar | Crossref | Medline33. Rossi, MC, Cristofaro, MR, Gentile, S, et al. Sex disparities in the quality of diabetes care: biological and cultural factors may play a different role for different outcomes: a cross-sectional observational study from the AMD Annals initiative. Diabetes Care 2013; 36: 3162–3168.
Google Scholar | Crossref | Medline34. de Jong, M, Oskam, MJ, Sep, SJS, et al. Sex differences in cardiometabolic risk factors, pharmacological treatment and risk factor control in type 2 diabetes: findings from the Dutch Diabetes Pearl cohort. BMJ Open Diabetes Res Care 2020; 8: e001365.
Google Scholar | Crossref | Medline35. Ferrara, A, Mangione, CM, Kim, C, et al. Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes: translating research into action for diabetes (TRIAD) study. Diabetes Care 2008; 31: 69–74.
Google Scholar | Crossref | Medline36. Power, ML, Schulkin, J. Sex differences in fat storage, fat metabolism, and the health risks from obesity: possible evolutionary origins. Br J Nutr 2008; 99: 931–940.
Google Scholar | Crossref | Medline37. Kotronen, A, Juurinen, L, Tiikkainen, M, et al. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. Gastroenterology 2008; 135: 122–130.
Google Scholar | Crossref | Medline38. Peters, SAE, Huxley, RR, Sattar, N, et al. Sex differences in the excess risk of cardiovascular diseases associated with type 2 diabetes: potential explanations and clinical implications. Curr Cardiovasc Risk Rep 2015; 9: 36.
Google Scholar | Crossref | Medline39. Van de Voorde, J, Pauwels, B, Boydens, C, et al. Adipocytokines in relation to cardiovascular disease. Metabolism 2013; 62: 1513–1521.
Google Scholar | Crossref | Medline40. Sorimachi, H, Obokata, M, Takahashi, N, et al. Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction. Eur Heart J 2021; 42: 1595.
Google Scholar | Crossref | Medline41. Rosito, GA, Massaro, JM, Hoffmann, U, et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 2008; 117: 605–613.
Google Scholar | Crossref | Medline42. Mendelsohn, ME, Karas, RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999; 340: 1801–1811.
Google Scholar | Crossref | Medline43. Ahmed, B, Bairey Merz, CN, Johnson, BD, et al. Diabetes mellitus, hypothalamic hypoestrogenemia, and coronary artery disease in premenopausal women (from the National Heart, Lung, and Blood Institute sponsored WISE study). Am J Cardiol 2008; 102: 150–154.
Google Scholar | Crossref | Medline44. Nappi, RE, Simoncini, T. Menopause transition: a golden age to prevent cardiovascular disease. Lancet Diabetes Endocrinol 2021; 9: 135–137.
Google Scholar | Crossref | Medline45. Hodis, HN, Mack, WJ, Henderson, VW, et al. Vascular effects of early versus late postmenopausal treatment with estradiol. N Engl J Med 2016; 374: 1221–1231.
Google Scholar | Crossref | Medline46. Iorga, A, Cunningham, CM, Moazeni, S, et al. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ 2017; 8: 33.
Google Scholar | Crossref | Medline47. Garcia, M, Mulvagh, SL, Bairey Merz, CN, et al. Cardiovascular disease in women: clinical perspectives. Circ Res 2016; 118: 1273–1293.
Google Scholar | Crossref | Medline48. Dhindsa, S, Ghanim, H, Batra, M, et al. Hypogonadotropic hypogonadism in men with diabesity. Diabetes Care 2018; 41: 1516–1525.
Google Scholar | Crossref | Medline49. Yao, QM, Wang, B, An, XF, et al. Testosterone level and risk of type 2 diabetes in men: a systematic review and meta-analysis. Endocr Connect 2018; 7: 220–231.